Cytogel Pharma, LLC

États‑Unis d’Amérique

 
Quantité totale PI 23
Rang # Quantité totale PI 64 451
Note d'activité PI 1,9/5.0    12
Rang # Activité PI 73 549
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

12 1
4 0
6 0
0
 
Dernier brevet 2025 - Polymer agonists of mu opioid re...
Premier brevet 2005 - Advantageous hydrogel composition
Dernière marque 2020 - CYT-1010
Première marque 2020 - CYT-1010

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Polymer agonists of mu opioid receptors. The subject invention provides compositions and methods...
2022 Invention Novel therapeutic uses of mu-opiate receptor peptides. The present invention pertains to novel u...
Invention Materials and methods for treatment of inflammation. The subject invention pertains to peptides ...
Invention Polymer agonists of mu opioid receptors. The subject invention provides compositions and methods ...
2021 Invention Advantageous salts of mu-opiate receptor peptides. The subject invention provides advantageous n...
Invention Advantageous mu-opiate receptor peptide compounds. The subject invention provides advantageous n...
2020 Invention Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof. The su...
Invention Materials and methods for treatment of inflammation. The subject invention pertains to peptides a...
P/S Analgesic preparations
2018 Invention Polymer agonists of mu opioid receptors. The subject invention provides compositions and m...
Invention Novel analgesic pharmaceutical formulations and uses thereof. The subject invention provides comp...
2013 Invention Advantageous salts of μ-opiate receptor peptides. The subject invention provides advantageous new...
Invention Novel therapeutic uses of mu-opiate receptor peptides. The present invention pertains to novel us...
2011 Invention Injectable microspheres. Injectable microspheres are obtained from double bond functionalized pol...
2010 Invention Advantageous mu-opiate receptor peptide compounds. The subject invention provides advantageous ne...
2008 Invention Advantageous salts of mu-opiate receptor peptides. The subject invention provides advantageous ne...
Invention Advantageous salts of mu-opiate receptor peptides. The subject invention provides advantage...
Invention Method for delivering an active agent using a hydrogel composition. New hydrogel, including a hyd...
2005 Invention Advantageous hydrogel composition. New hydrogel, including a hydrogel containing cationic BSA is ...